#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

The use of PET/ CT with a hypoxia marker (18F-MISO) in radiotherapy treatment planning


Authors: Tomáš Novotný 1;  Zdeněk Řehák 2;  Michal Budinský 3;  Petr Dvořáček 4;  Jiří Vašina 2;  Pavel Šlampa 1;  Marek Slávik 1
Authors‘ workplace: Klinika radiační onkologie LF MU a MOÚ, Brno 1;  Oddělení nukleární medicíny, MOU Brno 2;  Ústavní lékárna, MOÚ Brno 3;  Oddělení radiologické fyziky, MOÚ Brno 4
Published in: Klin Onkol 2021; 34(3): 241-243
Category: Oncology in Images
doi: https://doi.org/10.48095/ccko2021241


Sources
  1. Hodolič M, Fettich J, Kairemo K. Hypoxia PET tracers in EBRT dose planning in head and neck cancer. Curr Radiopharm 2015; 8(1): 32–37. doi: 10.2174/ 1874471008666150316222400.
  2. Watanabe S, Inoue T, Okamoto S et al. Combination of FDG-PET and FMISO-PET as a treatment strategy for patients undergoing early-stage NSCLC stereotactic radiotherapy. [online]. Available from: https:/ / ejnmmires.springeropen.com/ articles/ 10.1186/ s13550-019-0578-6.
  3. Specifické léčebné programy. [online]. Dostupné z: https:/ / www.radiomedic.cz/ produkty/ specificke-lecebne-programy/ 
  4. Pigorsch SU, Wilkens JJ, Kampfer S et al. Do selective radiation dose escalation and tumour hypoxia status impact the loco-regional tumour control after radio-chemotherapy of head & neck tumours? The ESCALOX protocol. Radiat Oncol 2017; 12(1): 45. doi: 10.1186/ s13014-017-0776-1.
Labels
Paediatric clinical oncology Surgery Clinical oncology
Topics Journals
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#